Maxona Pharmaceuticals, Inc. — Form D
Maxona Pharmaceuticals, Inc. of Malvern, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-13. The offering totals $5.0M, of which $900K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-06-13
- Form: D
- Accession: 0001857448-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $900K
- Remaining: $4.1M
- Investors: 15
- Date of first sale: 2025-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-548944
Issuer
- Name: Maxona Pharmaceuticals, Inc.
- CIK: 0001857448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 101 Lindenwood Drive, Malvern, PA, 19355
- Phone: 484.681.5626
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Shahin Fatholahi | Director | Malvern, PA |
| David Nakamura | Director | Malvern, PA |
| Behshad Sheldon | Director | Malvern, PA |
| Richard Brand | Executive Officer | Malvern, PA |
| Shahin Fatholahi | Executive Officer | Malvern, PA |
Other filings by this issuer (1)
More